.png){kind=icon}
.png){kind=icon}
Return
A regulatory perspective on the first approved EU application to reformulate an inhaled medicine with a gas propellant with reduced global warming potential
.png){kind=icon}
OA
AI
C
C
T
I
V
DOI：10.1002/bcp.70686.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3
Papers:
8.5K
Citations:
1.8W
Organization
Cited Papers